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Abstract—Mutation analysis evaluates test suites and testing
techniques by measuring how well they detect seeded defects
(mutants). Even though well established in research, mutation
analysis is rarely used in practice due to scalability problems
— there are multiple mutations per code statement leading to a
large number of mutants, and hence executions of the test suite.
In addition, the use of mutation to improve test suites is futile
for mutants that are equivalent, which means that there exists
no test case that distinguishes them from the original program.
This paper introduces two optimizations based on state infec-
tion conditions, i.e., conditions that determine for a test execution
whether the same execution on a mutant would lead to a
different state. First, redundant test execution can be avoided
by monitoring state infection conditions, leading to an overall
performance improvement. Second, state infection conditions can
aid in identifying equivalent mutants, thus guiding efforts to
improve test suites.
I. INTRODUCTION
Mutation analysis is a fault-based technique that assesses
the quality of a test suite by measuring the number of seeded
defects (mutants) that the test suite reveals (kills). However,
the number of such mutants is typically huge, making the
technique unscalable for large programs. Furthermore, some
of the mutants are equivalent, meaning that there exists no
test case that can distinguish the mutant from the original
version, such that attempts to generate tests to kill them are
futile. Unscalability and the equivalent mutant problem limit
the applicability of mutation analysis in practice.
This paper addresses these problems by exploiting state
infection conditions. A state infection condition determines
whether a test execution would lead to a different state on
a mutated version of the program. If this condition is true,
then the mutant differs from the original version at some
point during its execution. Although these conditions are well
known, there is further potential to use them to address the
problems of scalability and equivalent mutants.
To avoid unnecessary test executions and improve scala-
bility, state-of-the-art mutation analysis tools gather coverage
information in a preprocessing step. A test execution is skipped
if it would not reach the mutated code location. This can be
further improved by checking state infection conditions during
the preprocessing step. If a test does not achieve state infection
on a mutant, then the test cannot kill it, and hence there is
no need to execute the test for this mutant. Consequently,
state infection conditions reduce the overall number of test
executions. Note that a mutant that does not exhibit state
infection either indicates a weakness of the test suite or it
is equivalent with regard to all possible tests.
One use of mutation analysis is to improve a test suite by
adding new tests that kill each unkilled mutant. Yet, a mutant
might be unkilled because it is equivalent, i.e., no test exists
that would kill it. In this case any attempt to generate a test
to kill it is futile. This paper uses state infection conditions to
query constraint solvers. If such a state infection condition is
unsatisfiable, then this reveals an equivalent mutant.
In detail, the contributions of this paper are:
• Section II empirically compares the efficiency improve-
ments by exploiting two necessary conditions to kill a
mutant, namely mutation coverage and state infection.
• Section III presents a new approach based on state
infection conditions and symbolic execution that uses
constraint solvers to identify equivalent mutants.
• Section IV provides a case study of applying this ap-
proach to identify equivalent mutants in an example
application.
II. STATE INFECTION VS MUTATION COVERAGE
Mutation analysis executes a test suite on a set of mutants
to measure the test suite’s ability to kill the mutants. For some
mutants, it can be known in advance that a test suite cannot
kill them. In particular, if a test suite does not even execute
the mutated code, then no test needs to be executed on the
corresponding mutant. This is a simple yet powerful optimiza-
tion, as the mutation coverage of the test suites of real-world
applications is often small, sometimes even below 50% [6].
Even if a mutant is covered, it cannot be killed unless
its execution additionally causes a state infection [1]. For
expression-based mutations, such as the replacement of op-
erators or logical connectors, state infection means that the
resulting value of the mutated expression differs from the value
of the original expression. For example, the expression a>b
TABLE I
COMPARISON OF MUTATION COVERAGE WITH STATE INFECTION CONCERNING THE NUMBER OF EXECUTED MUTANTS AND THE TOTAL RUNTIME OF THE
MUTATION ANALYSIS PROCESS.
Total number of mutants Mutation coverage State infection
Generated Killed Executed mutants Total runtime* Executed mutants Total runtime*
itext 126,781 4,876 18,170 315 15,718 ( -13%) 279 ( -11%)
trove 72,959 3,523 6,137 49.6 5,242 ( -15%) 36.2 ( -27%)
jfreechart 68,503 13,132 36,298 582 31,165 ( -14%) 470 ( -19%)
joda-time 23,781 14,629 19,602 214 17,913 (-8.6%) 136 ( -36%)
commons-lang 21,056 14,780 20,196 48.9 18,120 ( -10%) 39.1 ( -20%)
jdom 10,800 8,187 10,266 108 9,780 (-4.7%) 82.1 ( -24%)
commons-io 7,319 3,288 4,255 4.20 3,686 ( -13%) 2.80 ( -33%)
jaxen 7,132 2,078 4,679 386 3,608 ( -23%) 221 ( -43%)
numerics4j 5,437 3,500 5,209 1.49 4,972 (-4.5%) 1.21 ( -19%)
avg ( -12%) ( -26%)
*Total runtime of mutation analysis in minutes (includes preprocessing).
and the mutated version a>=b only evaluate to a different out-
come if a equals b. This is exploited in weak mutation testing,
where a mutant is considered to be killed if it achieves state
infection. In contrast, strong mutation additionally requires a
propagation of the state infection to an observable output or
assertion failure. A key advantage of state infection is that it
can be determined without executing any mutants, but by only
checking state infection conditions during the execution of the
original version. Therefore, we propose to use state infection
also for strong mutation testing to determine whether a test
needs to be executed for a certain mutant.
In comparison with mutation coverage, the state infection
analysis causes an additional overhead when executing the
original version to determine whether this execution fulfills
the infection conditions. To compare the costs and benefits of
determining state infection, we conducted an empirical study
using the MAJOR [7] mutation analysis tool. Table I gives the
results for the nine open-source projects, which we investi-
gated by executing their corresponding JUnit test suites. When
compared to mutation coverage, the state infection approach
decreases the number of mutants that need to be analyzed by
12% and the total runtime of the mutation analysis process
by 26%, on average. Note that the total runtime includes
the preprocessing time, which is several orders of magnitude
smaller than the total runtime, and hence negligible.
III. CONSTRAINTS ON EQUIVALENT MUTANTS
Identifying equivalent mutants is crucial, not only for effi-
ciency reasons but also to avoid futile effort to generate tests
to kill them. As discussed in Section II, exploiting the state
infection as a necessary condition to kill a mutant improves
the runtime of the mutation analysis process. However, the
question remains whether the excluded mutants that fulfill the
reachability but not the state infection condition are either
equivalent or identify a weakness in the test suite.
This section presents a new and sound approach to weed out
equivalent mutants focusing on those that are covered but do
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Fig. 1. Combining dynamic analysis (Preprocessing) and constraint solving
to detect equivalent mutants. Note that I ⊆ C ⊆M .
not exhibit state infection. Figure 1 visualizes the complete
workflow with the following steps: First, it determines, in
the preprocessing step, the sets of covered and state-infected
mutants. Note that this step only involves a single execution
of the original program, which is instrumented to provide all
necessary information. The preprocessing step also computes
all covered mutants that do not manifest a state infection.
The corresponding set of these potentially equivalent mutants,
1 public int classify(int a, int b, int c){
2 if( a<=0 || b<= 0 || c<=0 ){
3 return INVALID;
4 }
5
6 if( a==b && a<=c ){
7 return EQUILATERAL;
8 }
9 ...
10 }
Original version:
a==c
Start backtracking
from this location
6 (a==c) != (a<=c)
AND
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AND
4 !(a<=0 || b<=0 || c<=0)
infection
reachability
Fig. 2. Determination of state infection conditions under which the expression
value of the mutant differs from the original version. A circle indicates the
line number for which the corresponding condition must hold.
represented by C − I , is obtained by subtracting the set of
state-infected mutants from the set of covered mutants.
For each of these mutants, the workflow thereafter generates
the constraints that have to be fulfilled to cause the state
infection by backtracking the path from the mutated location
to the entry point of the corresponding method. Intuitively, the
necessary constraints are composed of the reachability condi-
tions (i.e., backward symbolic execution) and the requirement
that the mutant’s value differs from the original one.
Finally, it employs a constraint solver to decide whether the
extracted constraints, which would yield a state infection, can
be satisfied. If the constraint solver reveals that the extracted
constraints are unsatisfiable, the mutant is equivalent for the
execution path chosen by the test, and does not need to be
considered again for a test case that follows the same control
flow. If the state infection has been shown to be unsatisfiable
for all paths reaching the mutant, then this proves that the
mutant is equivalent and can be completely removed from
the set of mutants. On the other hand, if the solver provides
a solution to the given constraints, the corresponding values
can be used to enhance the test suite. Note that the state
infection conditions may not be determinable (e.g., for loops)
or the constraint solver may not be able to solve them (e.g.,
unsupported arithmetic). In this case, the decision is unknown
and the corresponding mutant is treated as a killable mutant.
Figure 2 visualizes the determination of the state infection
condition for an example code fragment and also gives the
corresponding conditions that are necessary to reach the mu-
tant a<=c and to cause it to evaluate to a different value than
the original version a==c.
IV. CASE STUDY: EQUIVALENT TRIANGLE MUTANTS
We applied the approach of Section III to the well-known
triangle example, an application that classifies triangles. In
order to obtain an unbiased initial test suite (T1) for the triangle
program, we employed EVOSUITE [2] to generate a test suite
TABLE II
NUMBER OF EQUIVALENT AND KILLED MUTANTS OUT OF 17
INVESTIGATED AND POTENTIALLY EQUIVALENT MUTANTS.
Number of
mutants
Solver
decision
Approach
decision
Killed by
new test case
Precise
result
8 unsat equivalent no equivalent
8 sat killable yes killable
1 sat killable no equivalent
that satisfies 100% branch coverage. This generated test suite
consists of 14 test cases and also achieves 100% mutation
coverage, meaning that all mutants are reached and executed.
However, only 108 of the 125 executed mutants yield a state
infection. As previously stated, the strong mutation analysis
process only executes these 108 mutants since the remaining
17 mutants cannot be killed. Eventually, the generated test
suite kills 92 out of 108 state-infected mutants.
A. Equivalent Mutants due to Unsatisfiable Constraints
Since our approach aims at detecting equivalent mutants,
which are covered but cannot be killed due to unsatisfiable
state infection conditions, we focus on the 17 mutants that
potentially belong to this category of equivalent mutants.
For each of the 17 mutants, we manually performed back-
ward symbolic execution on all paths to the method entry and
included the condition that forces the mutated expression to
take a value that differs from the original one. The Z3 con-
straint solver then solved the constraints for each mutant. Z3
determined that 8 out of 17 constraints are indeed unsatisfiable.
Hence, the corresponding mutants are equivalent and could be
removed. Moreover, we used the computed solutions for the
constraints of the remaining 9 mutants to form additional test
cases, resulting in the test suite T2. These new tests not only
infected the state as required by the constraints, but also killed
further 8 of the 9 remaining mutants, thus leaving only one
undetected. Table II summarizes all results of this analysis.
B. Enhanced State Infection for Composed Expressions
So far, we considered the satisfiability of the state infection
conditions on the mutated expression, and these conditions
turned out to be quite powerful in detecting equivalent mutants.
However, executing the test suite T2 still results in 14 unkilled
yet state-infected mutants. These mutants can either indicate a
weakness in the test suite, or they are equivalent despite locally
infecting the state. One possible case where this might happen
is if the mutation is a subexpression of a composed expression.
To investigate whether this is the case, we strengthen the state
infection conditions for such mutants. Consider an example
derived from the triangle application with the inputs a=1,
b=2, c=3, and the following composed expressions:
(a+b) > c (original version)
(a*b) > c (mutated version)
TABLE III
COMPARISON OF THE INITIAL TEST SUITE (T1) AND THE TEST SUITES (T2
AND T3), WHICH ENHANCE T1 BASED ON STATE INFECTION FOR THE
MUTATED EXPRESSION (T2) AND THE OUTERMOST EXPRESSION (T3).
Test suite Number of mutants out of 125
Set Numberof tests Covered
State-
infected Killed
T1 14 125 108 92
T2 22 125 117 103
T3 33 125 117 116
For the given inputs, the mutant indeed manifests a state
infection, (i.e., (a*b) != (a+b)). However, this local state
infection has no effect on the outer expression since both
versions evaluate to false (i.e., (a*b)>c == (a+b)>c).
Hence, the mutant cannot be detected with the corresponding
inputs, even though it induces a locally infected state.
Therefore, we also determined the constraints to infect the
outermost expression for all remaining live mutants, in order
to assess the improvements of applying this enhanced state
infection. By analyzing the remaining 14 mutants, not killed
by T2, we found that all of the constraints for the outermost
expressions are satisfiable, i.e., no additional equivalent mutant
was detected. This suggests that focusing on state infection
directly on the mutated expression is sufficient to detect the
majority of the equivalent mutants. However, the case study
program and the corresponding number of mutants is small,
so we need to investigate this matter for larger programs.
Furthermore, the additional tests derived from the computed
solutions for the state infection of the outermost expression,
resulting in the test suite T3, were able to kill 13 of the 14
mutants. The remaining live mutant is again the one already
reported in Section IV-A. By manually inspecting this live
mutant, we discovered that it is equivalent due to unsatisfiable
constraints beyond the state infection of its outermost expres-
sion. Table III summarizes the results for the initial test suite
T1, and the enhanced test suites T2 and T3 (T1 ⊂ T2 ⊂ T3).
Note that some derived tests detect more than one mutant,
explaining why the increase of the number of tests is smaller
than the increase of the number of killed mutants. Concerning
the number of killed mutants, using state infection for the
outermost expression seems to be adequate for generating tests
that not only infect the state but also kill the mutant.
V. RELATED WORK
The idea of state infection conditions goes back to DeMillo
et al. [1], who identified reachability, infection, and propaga-
tion as the three necessary conditions to kill a mutant. Their
state infection conditions have since been used to drive test
generation (e.g., [1], [4]). In this context, the conditions have
also been used to avoid redundant test executions during fitness
evaluations in a search-based test generation approach [3]. In
contrast, our approach uses state infection during mutation
analysis, and avoids executing tests on mutants if they do not
infect the state. This extends the common strategy to measure
mutation coverage to reduce the number of test executions.
A commonly assumed workflow in mutation analysis is that
the developer applies the analysis to an existing test suite, and
uses the results to further improve the test suite. If a mutant
is not even covered, then this indicates that a new test case is
required, while a mutant that is covered but not killed might
identify a weak test oracle (e.g., a missing test assertion).
Schuler et al. [9] proposed to measure the impact of a mutant
in terms of invariant violations or changes in code coverage.
The impact of a mutant is correlated with its probability of be-
ing equivalent, such that improvement efforts should start with
the mutants with highest impact. However, covered mutants
without state infection have no impact per definition, leaving
the question of what to do about these. They might be equiv-
alent, or they might just be very difficult to kill, such that a
killing test would greatly improve the test suite. Our approach
addresses precisely this neglected category of mutants.
Besides impact analysis [9], there have been a number of
proposed techniques to address the equivalent mutant prob-
lem [5]. In particular, Nica and Wotawa [8] convert programs
to a constraint representation, and determine equivalence by
solving a constraint system consisting of original program and
mutant. In contrast, our approach only represents individual
program paths, and uses state infection conditions to check
whether mutants can infect the state, which results in simpler
constraints. State infection is a necessary but not sufficient
condition for non-equivalence, e.g., the state difference may
not propagate to an observable output. In our study, only one
out of 9 triangle mutants was equivalent despite state infection,
suggesting that this is an acceptable trade-off in order to
simplify the resulting constraint systems.
VI. CONCLUSIONS
Despite significant progress, mutation analysis still suffers
from problems concerning scalability and equivalent mutants.
This paper has presented two new optimizations to the muta-
tion analysis process. First, computing state infection, a neces-
sary condition to kill a mutant, during the initial test execution
can significantly reduce the overall number of mutants that
need to be analyzed. Second, as a further application of the
state infection conditions, a constraint solver can detect locally
equivalent mutants. It identified 8 out of 9 equivalent mutants
in our case study. Furthermore, by augmenting the test suite
with the computed solutions of the constraint solver, we were
able to kill 24 previously undetected, yet covered mutants.
This paper has presented the ideas and some initial results,
but the bulk of implementation remains to be done in order to
perform large scale experiments.
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